HomeComparePKBO vs JEPQ

PKBO vs JEPQ: Dividend Comparison 2026

PKBO yields 8888.89% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PKBO wins by $17290949737713800.00M in total portfolio value
10 years
PKBO
PKBO
● Live price
8888.89%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$17290949737713800.00M
Annual income
$16,916,578,202,775,594,000,000.00
Full PKBO calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — PKBO vs JEPQ

📍 PKBO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPKBOJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PKBO + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PKBO pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PKBO
Annual income on $10K today (after 15% tax)
$755,555.56/yr
After 10yr DRIP, annual income (after tax)
$14,379,091,472,359,256,000,000.00/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, PKBO beats the other by $14,379,091,472,359,256,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PKBO + JEPQ for your $10,000?

PKBO: 50%JEPQ: 50%
100% JEPQ50/50100% PKBO
Portfolio after 10yr
$8645474868856900.00M
Annual income
$8,458,289,101,387,797,000,000.00/yr
Blended yield
97.83%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PKBO buys
0
JEPQ buys
0
No recent congressional trades found for PKBO or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPKBOJEPQ
Forward yield8888.89%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$17290949737713800.00M$44.8K
Annual income after 10y$16,916,578,202,775,594,000,000.00$2,152.59
Total dividends collected$17265985963886318.00M$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: PKBO vs JEPQ ($10,000, DRIP)

YearPKBO PortfolioPKBO Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$899,589$888,888.89$11,930$1,110.39+$887.7KPKBO
2$75,694,763$74,732,202.61$14,133$1,224.34+$75.68MPKBO
3$5,957,858,933$5,876,865,536.53$16,632$1,340.46+$5957.84MPKBO
4$438,676,028,838$432,301,119,780.33$19,454$1,457.97+$438676.01MPKBO
5$30,217,280,421,144$29,747,897,070,286.80$22,626$1,576.08+$30217280.40MPKBO
6$1,947,399,451,993,550$1,915,066,961,942,926.00$26,175$1,694.09+$1947399451.97MPKBO
7$117,429,004,658,116,600$115,345,287,244,483,520.00$30,133$1,811.32+$117429004658.09MPKBO
8$6,625,994,131,926,989,000$6,500,345,096,942,805,000.00$34,531$1,927.17+$6625994131926.95MPKBO
9$349,879,939,194,586,330,000$342,790,125,473,424,500,000.00$39,403$2,041.08+$349879939194586.25MPKBO
10$17,290,949,737,713,800,000,000$16,916,578,202,775,594,000,000.00$44,787$2,152.59+$17290949737713800.00MPKBO

PKBO vs JEPQ: Complete Analysis 2026

PKBOStock

Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. The company's proprietary toxin, PH-1 or Thailanstatin, a spliceosome modulator is being used to generate its first pipeline of novel ADC product candidates to address unmet needs in cancer patients. Its lead product candidate, PHP-303, is a small molecule awaiting Phase II dose clinical study in the orphan disease Alpha1 anti-trypsin deficiency (AATD). The company is based in Palo Alto, California.

Full PKBO Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this PKBO vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PKBO vs SCHDPKBO vs JEPIPKBO vs OPKBO vs KOPKBO vs MAINPKBO vs XYLDPKBO vs QYLDPKBO vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.